Protective effects of simvastatin, an HMGCoA reductase inhibitor, against oxidative damage in experimental diabetic rats

International Journal of PharmTech Research

Volumn 3, Issue 3, 2011, Pages 1780-1795

  Mohamadin, Ahmed M ^a,b   Elberry, Ahmed A ^c   Gawad, Hala S Abdel ^a   Morsy, Gehan M ^a   Al Abbasi, Fahad A ^c  

^a TAIBAH UNIVERSITY   (Saudi Arabia)

^b Cairo University   (Egypt)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Diabetes; Oxidative stress; Simvastatin; Streptozotocin

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; ALANINE AMINOTRANSFERASE; ASCORBIC ACID; ASPARTATE AMINOTRANSFERASE; CATALASE; CREATININE; GLIBENCLAMIDE; GLUCOSE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HEMOGLOBIN; HEMOGLOBIN A1C; LIPID; MALONALDEHYDE; SIMVASTATIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UREA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIET RESTRICTION; DRUG EFFECT; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; IN VITRO STUDY; KIDNEY PARENCHYMA; LIVER PARENCHYMA; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; STREPTOZOCIN DIABETES; UREA BLOOD LEVEL; VITAMIN BLOOD LEVEL;

EID: 79961135739     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. World Health Organization. Prevalence of diabetes worldwide. Available at http://www.who.int/mediacentre/factsheets/fs312/ en/index.html, accessed in 6.6.2010.
2. Chan, J.C.N., Malik, V., Jia, W., Kadowaki, T., Yajnik, C.S., Yoon, K.-H. and Hu, F.B. Diabetes in Asia: Epidemiology, Risk Factors, and Pathophysiology. JAMA 301: 2129-2140, 2009.
3. Maritim AC, Sanders RA, Watkins JB. Diabetes, oxidative stress, and antioxidants: A review. J. Biochem. Mol. Toxicol. 2003; 17: 24-38.
4. Likidlilid A, Patchanans N, Peerapatdit T, Sriratanasathavorn C. Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients. J Med Assoc Thai. 2010 Jun;93(6):682-693.
5. Venturini CD, Merlo S, Souto AA, Fernandes Mda C, Gomez R, Rhoden CR. Resveratrol and red wine function as antioxidants in the nervous system without cellular proliferative effects during experimental diabetes. Oxid Med Cell Longev. 2010 Nov-Dec;3(6):434-441.
6. Acharya JD, Ghaskadbi SS. Islets and their antioxidant defense. Islets. 2010 Jul-Aug;2(4):225-235.
7. Szkudelski, T., 2001. The mechanism of alloxan and streptozotocin action in β-cells of the rat pancreas. Physiol. Res. 50, 537-546.
8. Al-Rawi NH. Oxidative stress, antioxidant status and lipid profile in the saliva of type 2 diabetics. Diab Vasc Dis Res. 2011 Jan;8(1):22-28.
9. Tripathi UN, Chandra D. Anti-hyperglycemic and anti-oxidative effect of aqueous extract of Momordica charantia pulp and Trigonella foenum graecum seed in alloxan-induced diabetic rats. Indian J Biochem Biophys. 2010 Aug;47(4):227-233.
10. Alvarez, J.F., Barbera, A., Nadal, B., Barcelo-Batllori, S., Piquer, S., Claret, M., Guinovart, J.J., Guinovart, Gomis, R., 2004. Stable and functional regeneration of pancreatic beta-cell population in n-STZ rats treated with tungstate. Diabetologia 47, 470-477.
11. Maron DJ, Fazio S, Linton MF: Current perspectives on statins. Circulation 2000; 101: 207-213
12. Ganesh SK, Nass CM, Blumenthal RS. Anti-atherosclerotic effects of statins: lessons from prevention trials. J Cardiovasc Risk 2003;10:155-159.
13. Wierzbicki AS, Poston R, Ferro A. The lipid and non-lipid effects of statins. Pharmacol Ther 2003;99:95-112.
14. Liao JK, Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 2005;45:89-118.
15. Araújo-Filho I, Jácome DT, Rêgo AC, Azevedo IM, Egito ES, Medeiros AC. [Effect of the simvastatin in abdominal sepsis of diabetic rats]. Rev Col Bras Cir. 2010 Feb;37(1):39-44.
16. Laing T, Hanson R, Chan F, Bouchier-Hayes D. Effect of pravastatin on experimental diabetic wound healing. J Surg Res. 2010 Jun 15;161(2):336-340.
17. Kostapanos MS, Liberopoulos EN, Elisaf MS. Statin pleiotropy against renal injury. J Cardiometab Syndr. 2009 Winter;4(1):E4-E9.
18. Ansquer JC, Crimet D, Foucher C. Fibrates and statins in the treatment of diabetic retinopathy. Curr Pharm Biotechnol. 2011 Mar 1;12(3):396-405.
19. Yao XM, Ye SD, Zai Z, Chen Y, Li XC, Yang GW, Wang YX, Chen K. Simvastatin protects diabetic rats against kidney injury through the suppression of renal matrix metalloproteinase-9 expression. J Endocrinol Invest. 2010 May;33(5):292-296.
20. Kuzelová M, Adameová A, Sumbalová Z, Paulíková I, Harcárová A, Svec P, Kucharská J. The effect of simvastatin on coenzyme Q and antioxidant/oxidant balance in diabetic-hypercholesterolaemic rats. Gen Physiol Biophys. 2008 Dec;27(4):291-298.
21. Cumaoǧlu A, Ozansoy G, Irat AM, Aricioǧlu A, Karasu C, Ari N. Effect of long term, none cholesterol lowering dose of fluvastatin treatment on oxidative stress in brain and peripheral tissues of streptozotocin-diabetic rats. Eur J Pharmacol. 2011; 654(1):80-85.
22. Stoll LL, McCormick ML, Denning GM, Weintraub NL. Antioxidant effects of statins. Drugs Today (Barc) 2004;40:975-990.
23. Mazor R, Shurtz-Swirski R, Farah R, et al. Primed polymorphonuclear leukocytes constitute a possible link between inflammation and oxidative stress in hyperlipidemic patients. Atherosclerosis, vol, 197 (2), 937-943, 2008.
24. Edlund J, Fasching A, Liss P, Hansell P, Palm F. The roles of NADPH-oxidase and nNOS for the increased oxidative stress and the oxygen consumption in the diabetic kidney. Diabetes Metab Res Rev. 2010 Jul;26(5):349-356.
25. Mitsuda H, Yuasumoto K, Iwami K. Antioxidation action of indole compounds during the autoxidation of linoleic acid. Eiyo to Shokuryo 1996;19:210-214.
26. Shimada, K., Fujikawa, K., Yahara, K., & Nakamura, T. (1992). Antioxidative properties of xanthin on autoxidation of soybean oil in cyclodextrin emulsion. Journal of Agricultural and Food Chemistry, 40, 945-948.
27. Siddique O, Sun Y, Lin JC, Chien YW. Facilitated transdermal transport of insulin. J. Pharm. Sci. 1989; 76: 341-345.
28. Mooradian AD, Haas MJ, Batejko O, Hovsepyan M, Feman SS. Statins ameliorate endothelial barrier permeability changes in the cerebral tissue of streptozotocin-induced diabetic rats. Diabetes 2005, 54:2977-2982.
29. Lowry OH, Rosenbrough NJ, Farr AL, Randall R. Protein determination using Folin-Cicocalteu reagent. J. Biol. Chem. 1951; 193: 265-278.
30. Trinder P. Determination of blood glucose using an oxidase-perioxidase system with a non-carcinogenic chromogen. J Clinical Pathology. 1969;22:158-161.
31. Friedewald WT, Fredrickson DS, Levy RJ. Estimation of concentration of low density lipoprotein cholesterol in plasma without use of the preparation ultracentrifuge. J Clin Chem. 1972;18:449.
32. Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Amer. J. Clin. Pathol. 1957; 28:56-63.
33. Ellman G. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959; 82: 70-77.
34. Omaye, S. T., Turnbull, J. D., & Sauberlich, H. E. (1979). Selected methods for the determination of ascorbic acid in animals cells, tissues and fluids. Methods in Enzymology, 62, 1-11.
35. Uchiyama M, Mihara M. Determination of malondialdehyde precursors in tissues by thiobarbituric acid test. Anal. Biochem. 1978; 86: 271-278.
36. Marklund S, Marklund G. Involvement of superoxide anion radical in the autoxidation of pyrogallol and convenient assay for superoxide dismutase. Eur. J. Biochem. 1974; 47: 469-474.
37. Aebi H. Catalase. In: Bergmeyer HU (ed.). Methods in Enzymatic Analysis, Vol. 3. Academic Press, New York. 1983; 276-286.
38. Lawrence RA, Burk RF. Glutathione peroxidase activity in seleniumdeficient rat liver. Biochem. Biophys. Res. Commun. 1976; 71: 952-958.
39. Hiramatsu, K., Arimori, S., 1988. Increased superoxide production by mononuclear cells of patients with hypertriglyceridemia and diabetes. Diabetes 37, 832-837.
40. Wolff, S.P., Jang, Z.Y., Hunt, V.J., 1991. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free. Radic. Biol. Med. 10, 339-352.
41. Hauggard, N., 1968. Cellular mechanism of oxygen toxicity. Physiol. Rev. 48, 311-373.
42. Sanders, R. A., Rauscher, F. M., & Watkins, J. B., (2001). Effects of quercetin on antioxidant defense in streptozotocin-induced diabetic rats. Journal of Biochemical and Molecular Toxicology, 15, 143-149.
43. Yabe-Nishimura, C. (1998). Aldose reductase in glucose toxicity: A potential target for the prevention of diabetic complications. Pharmacological Reviews, 50, 21-33.
44. Elgawish, A., Glomb, M., Friedlander, M., & Monnier, V. M. (1996). Involvement of hydrogen peroxide in collagen cross-linking by high glucose in vitro and in vivo. Journal of Biological Chemistry 271, 12964-12971.
45. Golbidi S, Ebadi SA, Laher I. Antioxidants in the treatment of diabetes. Curr Diabetes Rev. 2011 Mar;7(2):106-125.
46. Matikainen N, Kahri J, Taskinen MR. Reviewing statin therapy in diabetes--towards the best practise. Prim Care Diabetes. 2010 Apr;4(1):9-15.
47. Imaeda, A., Kaneko, T., Aoki, T., Kondo, Y., Nakamura, N., Nagase, H. and Yoshikawa, T. (2002), Antioxidative effects of fluvastatin and its metabolites against DNA damage in streptozotocin treated mice. Food and Chemical Toxicology, 40, 1415-1422.
48. Panda SP, Haldar PK, Bera S, Adhikary S, Kandar CC. Antidiabetic and antioxidant activity of Swietenia mahagoni in streptozotocin-induced diabetic rats. Pharm Biol. 2010 Sep;48(9):974-979.
49. Yu, B. P. (1994). Cellular defense against damage from reactive oxygen species. Physiological Review, 74, 139-162.
50. Hunt, J. V. (1996). Ascorbic acid and diabetes mellitus. Subcellular Biochemistry, 25, 369-405.
51. Levine, W. G. (1990). Interaction of ascorbic acid and a-tocopherol. Annals of Nutrition Academy of Sciences, 498, 186-199.
52. May JM, Qu ZC. Ascorbic acid prevents oxidant-induced increases in endothelial permeability. Biofactors. 2011 37(1):46-50.
53. Pitocco D, Zaccardi F, Di Stasio E, Romitelli F, Santini SA, Zuppi C, Ghirlanda G. Oxidative stress, nitric oxide, and diabetes. Rev Diabet Stud. 2010 Spring;7(1):15-25.
54. Sefi M, Fetoui H, Lachkar N, Tahraoui A, Lyoussi B, Boudawara T, Zeghal N. Centaurium erythrea (Gentianaceae) leaf extract alleviates streptozotocin-induced oxidative stress and β-cell damage in rat pancreas. J Ethnopharmacol. 2011 Mar 23.
55. Santhakumari, A., Prakasam, A., & Pugalendi, K. V. (2003). Modulation of oxidative stress parameters by treatment with Piper betle leaf in streptozotocin induced diabetic rats. Indian Journal of pharmacology, 35, 373-378.
56. Satheesh, M. A., & Pari, L. (2004). Antioxidant effect of Boerhavia diffusa L. in tissue of alloxan induced diabetic rats. Indian Journal of Experimental Biology, 42(10), 989-992.
57. Argano, M., Brignardello, E., Tamagno, O., & Boccuzzi, G. (1997). Dehydroep-piandrosterone administration prevents the oxidative damage induced by acute hyperglycaemia in rats. Journal of Endocrinology, 155, 233-240
58. Pigeolet, E., Corbisier, P., Houbion, A., Lambert, D., Michiels, C., Raes, M., et al. (1990). Glutathione peroxidase, superoxide dismutase and Catalase inactivation by peroxides and oxygen derived free radicals. Mechanisms of Ageing and Development, 51, 283-297.
59. Sindhu, R. K., Koo, J. R., Roberts, C. K., & Vaziri, N. D. (2004). Dysregulation of hepatic superoxide dismutase, catalase and glutathione peroxidase in diabetes response to insulin and antioxidant therapies. Clinical and Experimental Hypertension, 26, 43-53.